Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Surveillance results: 2016-2017

From April 1^st, 2016 to March 31^st, 2017, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,835,605 patient days (Table 1). Together, these facilities reported 66 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI) acquired during a current or previous hospitalization (categories 1a and 1b). The HA-MRSA-BSI incidence rate was 0.14 per 10,000 patient days. While this incidence rate has been declining for the past five years, this year was comparable to the last one. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 12.…

Vancomycin-Resistant Enterococci Infections
Surveillance results: 2016-2017

From April 1^st, 2016 to March 31^st, 2017, 89 healthcare facilities took part in the surveillance of vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,827,659 patient days (Table 1). These facilities reported 44 healthcare-associated VRE (HA-VRE) infections, either acquired during a current or previous hospitalization (categories 1a and 1b). The HA-VRE infection rate was 0.09 per 10,000 patient days. This incidence rate was down from 2015-2016. The acquisition rate of HA-VRE colonization (cat. 1a and 1b) in 2016-2017 was 7.43 per 10,000 patient days and was lower compared to 2015-2016. For all results, analyses include facilities that participated for a minimum of 11 periods. Data were extracted on June 1^st…

Carbapenemase-Producing Gram Negative Bacilli Infections
Surveillance results: 2016-2017

From April 1^st, 2016, to March 31^st, 2017, 82 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 4,448,999 patient days (Table 1). These facilities reported 17 healthcare-associated CPGNB (HA-CPGNB) infections among patients who acquired their strain during a current or previous hospitalization (categories 1a and 1b). The incidence rate of HA-CPGNB infection was 0.04 per 10,000 patient days. The acquisition rate of HA-CPGNB colonization was 0.57 per 10,000 patient days. Eight infections were observed among healthcare facilities that joined the surveillance this year. Two teaching and one non-teaching facilities discontinued their participation…

Clostridium difficile–Associated Diarrhea
Surveillance results: 2016-2017

From April 1^st, 2016 to March 31^st, 2017, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,022,104 patient days (Table 1). These participating facilities reported 2,330 healthcare-associated CDAD (HA-CDAD), either acquired during a current or previous hospitalization (categories 1a and 1b). The HA-CDAD incidence rate was 4.64 cases per 10,000 patient days. This incidence rate has declined for a third consecutive year and this decline was statistically and significantly lower than the 2015–2016 rate. The 10-day fatality rate was 6.3% (n = 130) while the 30-day fatality rate was 12.4% (n = 258). In total, 14 (0.7%) colectomies were rep…

Hospital-Wide Healthcare-associated Bloodstream Infections
Surveillance results: 2016-2017

From April 1^st, 2016, to March 31^st, 2017, 89 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,830,348 patient days (Table 1). Participating facilities reported 3,167 BSIs in 2,982 patients. The total incidence rate was 5.43 cases per 10,000 patient days. The incidence rate in 2016–2017 is stable compared with the average rate for 2012–2016. Two non-teaching facilities joined the program in 2016–2017. Data were extracted on May 5^th, 2017.

Update: October 5, 2017
Version française

Tab…

Central Line–Associated Bloodstream Infections in Intensive Care Units
Surveillance results: 2016-2017

From April 1^st, 2016, to March 31^st, 2017, 69 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 135,114 catheter days (Table 1). Participating ICUs report 133 CLABSIs in 125 patients. Incidence rates are 0.91 per 1,000 catheter days in coronary ICUs, 0.62 in teaching adult ICUs, 0.46 in non-teaching adult ICUs, 2.16 in pediatric ICUs and 2.78 in neonatal ICUs. The incidence rates in 2016–2017 are lower compared to 2012–2016 in neonatal ICUs while they remain statistically stable in other ICU types. Compared to 2015-2016, one adult non-teaching ICUs with less than 10 beds has stopped participating to surveillance while two coro…

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients
Surveillance results: 2016-2017

From April 1^st, 2016, to March 31^st, 2017, 48 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 57,570 patient-periods (Table 1). Participating units reported 127 VARBSIs in 120 patients. Patient-periods involving a fistula account for 40.7% of patient-periods. The VARBSI incidence rate is 0.06 cases per 100 patient-periods for patients with an arteriovenous (AV) fistula, 0.10 for patients with a synthetic fistula (graft), 0.32 for patients with a tunneled catheter and 1.24 for patients with a non-tunneled catheter. In 2016–2017, incidence rates for tunneled and non-tunneled catheters have significant…

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients
Surveillance results: 2013-2014

From April 1^st, 2013, to March 31^st, 2014, 44 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,878 patient-periods (Table 1). Participating units reported 157 VARBSIs in 149 patients. Patient-periods involving a fistula accounted for 44.9% of patient-periods. The VARBSI incidence rate was 0.10 cases per 100 patient-periods for patients with an arteriovenous (AV) fistula, 0.22 for patients with a synthetic fistula (graft), 0.38 for patients with a permanent catheter and 6.20 for patients with a temporary catheter. In 2013-2014, incidence rates were stable for patients with a graft and for patients…

Hospital-Wide Healthcare-associated Bloodstream Infections
Surveillance results: 2013-2014

From April 1^st, 2013, to March 31^st, 2014, 77 healthcare facilities took part on a voluntary basis in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,149,763 patient-days (Table 1). Participating facilities reported 2,689 BSIs in 2,495 patients. The total incidence rate was 5.4 cases per 10,000 patient-days. The incidence rate in 2013-2014 was significantly lower compared with the average rate for 2009-2013 in facilities that took part in both surveillance periods. Two teaching and 11 non-teaching facilities that were not included in the 2012-2013 study joined the program in 2013-2014. Data was extracted on May 15^th, 2014. 

Central Line–Associated Bloodstream Infections in Intensive Care Units
Surveillance results: 2013-2014

From April 1^st, 2013, to March 31^st, 2014, 70 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 132,376 catheter-days (Table 1). Participating ICUs reported 165 CLABSIs in 149 patients. Incidence rates were 0.65 per 1,000 catheter-days in coronary ICUs, 0.71 in teaching adult ICUs, 0.77 in non-teaching adult ICUs, 2.48 in pediatric ICUs and 4.01 in neonatal ICUs. The incidence rates in 2013-2014 were lower compared to 2009-2013 in teaching and non-teaching adult ICUs as well as in neonatal ICUs while pediatric and coronary ICUs pooled mean rates remained statistically stable. Compared to 2012-2013, two adult n…